| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 981 | 771 | 727 | 736 | 569 | 474 | 414 | 433 | 437 | 397 | 398 | 354 |
| Expenses | 877 | 656 | 631 | 570 | 478 | 426 | 355 | 373 | 314 | 270 | 265 | 260 |
| EBITDA | 104 | 115 | 96 | 166 | 91 | 48 | 60 | 60 | 123 | 127 | 133 | 94 |
| Operating Profit % | -0 % | 5 % | 4 % | -1 % | 3 % | 3 % | 7 % | 7 % | 17 % | 19 % | 26 % | 27 % |
| Depreciation | 4 | 4 | 4 | 3 | 3 | 13 | 12 | 10 | 6 | 3 | 2 | 2 |
| Interest | 0 | 0 | 1 | 6 | 2 | 6 | 8 | 5 | 2 | 2 | 1 | 1 |
| Profit Before Tax | 93 | 111 | 92 | 158 | 86 | 29 | 40 | -4 | 115 | 123 | 130 | 130 |
| Tax | 14 | 39 | 35 | 79 | 34 | 19 | 19 | -0 | 12 | 38 | 30 | 35 |
| Net Profit | 79 | 73 | 57 | 78 | 52 | 10 | 21 | -4 | 103 | 85 | 101 | 95 |
| EPS in ₹ | 24.75 | 62.04 | 19.10 | 28.43 | 20.97 | 4.08 | 8.46 | -1.51 | 41.86 | 34.50 | 40.87 | 37.74 |
Novartis
Novartis
1,323.00
+113.20
(9.36%)
Market Cap
3,266.59 Cr
PE Ratio
32.03
Volume
82,537.00
Day High - Low
1,348.00 - 1,209.00
52W High-Low
1,275.00 - 950.00
There are 2 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
3,266.59 Cr
EPS
37.74
PE Ratio
32.03
PB Ratio
3.65
Book Value
331.23
EBITDA
94.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
12.85
Debt to Equity
0.01
Actual
Company News
View All News
Novartis India Limited issues corrigendum to its April 16, 2026 postal ballot notice, correcting resolution type for Ms. Gowree Gokhale's appointment from 'Ordinary' to 'Special Resolution'.
Novartis India confirmed publication of its audited Q4 & FY26 financial results in Financial Express and Navshakti on May 13, 2026, per Regulation 47 of SEBI LODR.
Novartis India Limited published newspaper advertisements on April 17, 2026, confirming completion of e-mailing postal ballot notices to members under SEBI regulations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,880.30 | #1 4,51,146.95 | 41.23 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 62.59 | |
6,893.00 | 1,82,987.49 | 74.03 | 9,712.00 | 18.67 | 2,191 | -1.02 | 67.94 | |
4,429.20 | 1,49,904.25 | 66.40 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.71 | |
1,399.50 | 1,13,048.91 | 29.49 | 27,711.70 | -2.46 | 3,783 | -55.32 | 62.25 | |
1,321.90 | 1,10,331.46 | 26.78 | 33,593.30 | -0.44 | 3,998 | -86.05 | 56.14 | |
2,583.90 | 1,06,664.70 | 57.10 | 12,744.20 | 20.90 | 2,007 | 31.75 | 76.93 | |
1,040.85 | 1,04,733.86 | 20.40 | 23,511.00 | 18.55 | 4,615 | 7.82 | 70.41 | |
2,285.50 | 1,04,457.23 | #1 19.52 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 47.81 | |
1,517.50 | 88,136.65 | 25.21 | 32,345.60 | 9.43 | 3,484 | 7.59 | 72.25 | |
1,361.10 | 73,479.88 | 81.56 | 6,812.90 | #1 21.03 | 884 | 21.18 | 83.04 |
Growth Rate
Revenue Growth
-11.02 %
Net Income Growth
-6.13 %
Cash Flow Change
-34.24 %
ROE
12.33 %
ROCE
0.56 %
EBITDA Margin (Avg.)
-28.52 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 1,246 | 1,433 | 1,150 | 1,111 | 982 | 1,078 | 1,002 | 958 | 983 | 925 | 948 | 978 |
| Fixed Assets | 9 | 7 | 6 | 5 | 15 | 76 | 64 | 24 | 19 | 7 | 5 | 3 |
| Current Assets | 1,063 | 1,264 | 973 | 952 | 807 | 813 | 723 | 709 | 677 | 699 | 746 | 768 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53 |
| Other Assets | 1,238 | 1,426 | 1,144 | 1,106 | 968 | 1,001 | 938 | 934 | 964 | 918 | 943 | 0 |
| Total Equity & Liabilities | 1,246 | 1,433 | 1,150 | 1,111 | 982 | 1,078 | 1,002 | 958 | 983 | 925 | 948 | 978 |
| Current Liabilities | 211 | 205 | 183 | 330 | 185 | 233 | 159 | 216 | 160 | 157 | 142 | 145 |
| Non Current Liabilities | 33 | 35 | 47 | 47 | 38 | 124 | 132 | 50 | 48 | 23 | 21 | 16 |
| Total Equity | 1,002 | 1,194 | 920 | 734 | 759 | 721 | 711 | 692 | 776 | 745 | 785 | 818 |
| Reserve & Surplus | 986 | 1,178 | 906 | 721 | 747 | 708 | 699 | 679 | 763 | 733 | 773 | 806 |
| Share Capital | 16 | 16 | 14 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 622 | -613 | 51 | -38 | 50 | -9 | -11 | 90 | -139 | 26 | 7 |
| Investing Activities | 719 | -631 | 424 | 69 | 274 | 56 | 95 | 87 | -153 | 33 | -3 |
| Operating Activities | -60 | 57 | -41 | 161 | -194 | -23 | -69 | 39 | 45 | 113 | 75 |
| Financing Activities | -38 | -39 | -332 | -268 | -30 | -41 | -37 | -36 | -31 | -121 | -64 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.32 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.17 % |
| DIIs | 0.79 % | 0.84 % | 0.78 % | 0.78 % | 0.78 % | 0.78 % | 0.79 % | 0.79 % | 0.78 % | 0.76 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.64 % | 0.53 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.34 % | 23.03 % | 23.09 % | 22.98 % | 22.88 % | 22.94 % | 23.02 % | 23.01 % | 23.03 % | 23.08 % | 23.29 % | 23.21 % | 22.95 % | 23.04 % | 23.05 % | 23.01 % | 23.11 % | 22.95 % | 22.92 % | 22.67 % | 23.25 % |
| Others | 5.20 % | 5.46 % | 5.45 % | 5.56 % | 5.66 % | 5.60 % | 5.52 % | 5.52 % | 5.51 % | 5.48 % | 5.18 % | 5.39 % | 5.65 % | 5.57 % | 5.55 % | 5.59 % | 5.49 % | 5.66 % | 5.68 % | 5.83 % | 5.36 % |
| No of Share Holders | 41,572 | 43,784 | 45,141 | 44,640 | 44,370 | 43,996 | 43,275 | 42,622 | 41,947 | 43,343 | 43,992 | 43,128 | 41,239 | 39,265 | 39,596 | 38,926 | 39,133 | 39,040 | 39,353 | 39,468 | 38,116 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 10 | 10 | 10 | 47.5 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 1.81 | 1.7 | 1.77 | 7.07 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Aug 2021 |  Dividend | ₹ 10.00 /share | 17 Aug 2021 | 906.60 | 805.65 |
| 22 Jul 2022 | Dividend | ₹ 10.00 /share | 20 Jul 2022 | 610.40 | 653.30 |
| 21 Jul 2023 | Dividend | ₹ 37.50 /share | 20 Jul 2023 | 624.80 | 828.65 |
| 21 Jul 2023 | Dividend | ₹ 10.00 /share | 20 Jul 2023 | 624.80 | 828.65 |
| 24 Jul 2024 | Dividend | ₹ 25.00 /share | 23 Jul 2024 | 1,053.80 | 1,116.90 |
| 31 Jul 2024 |  Annual General Meeting | NA | 31 Jul 2024 | 1,053.80 | 1,176.65 |
| 25 Oct 2024 |  Quarterly Result Announcement | NA | 25 Oct 2024 | 1,164.25 | 1,057.05 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 942.05 | 903.55 |
| 09 May 2025 | Quarterly Result Announcement | NA | 09 May 2025 | 830.10 | 797.40 |
| 23 Jul 2025 | Dividend | ₹ 25.00 /share | 23 Jul 2025 | 797.40 | 1,061.45 |
| 29 Jul 2025 | Quarterly Result Announcement | NA | 29 Jul 2025 | 1,002.90 | 993.65 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 797.40 | 995.75 |
| 28 Oct 2025 | Quarterly Result Announcement | NA | 28 Oct 2025 | 892.00 | 858.35 |
| 28 Jan 2026 | Quarterly Result Announcement | NA | 28 Jan 2026 | 775.70 | 800.75 |
| 12 May 2026 | Quarterly Result Announcement | NA | 12 May 2026 | 970.80 | 1,182.50 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
1 day ago
1 day agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoCorrigendum To The Notice Of Postal Ballot Issued On April 16 2026 For The Appointment Of Ms. Gowree Gokhale (DIN: 09351661) As An Independent Director.5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication7 days ago
7 days agoIntegrated Financial Results For The Quarter And Financial Year Ended March 31 2026.8 days ago
8 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday May 12 2026 To Approve The Audited Financial Results For The Quarter And The Financial Year Ended March 31 2026.8 days ago
8 days agoFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2026
Apr 23, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 17, 2026
Apr 17, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 16, 2026
Apr 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2026
Apr 13, 2026Disclosure Under Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover Regulations 2011)Apr 07, 2026
Apr 07, 2026Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited (The Company) And Closure Of Trading Window.Mar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Intimation Of The Receipt Of Delhi High Court Order Admitting Company Petition In The Matter Of Novartis India Limited Vs. Commissioner Of Trade And Taxes (W.P.(C) 3892/2026)Mar 30, 2026
Mar 30, 2026Intimation Under Reg 30 Of SEBI LODR Of Receipt Of TDS Order As Per Income Tax ActMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-CessationMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2026
Mar 27, 2026Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (The Company) Held Today I.E. Friday March 27 2026.Mar 27, 2026
Mar 27, 2026Intimation Of Receipt Of Draft Letter Of Offer Received From Manager To Open Offer (Axis Capital Limited).Mar 06, 2026
Mar 06, 2026Draft Letter of OfferMar 06, 2026
Mar 06, 2026Detailed Public StatementFeb 26, 2026
Feb 26, 2026Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 26, 2026
Feb 26, 2026Open Offer - Public AnnouncementFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 19, 2026
Feb 19, 2026Rumour verification - Regulation 30(11)Jan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2026
Jan 29, 2026Integrated Filing (Financial) For The Quarter Ended December 31 2025.Jan 28, 2026
Jan 28, 2026Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (The Company) Held On Wednesday January 28 2026.Jan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Novartis India Limited To Inter Alia Consider And Approve The Unaudited Financial Results For Quarter Ended December 31 2025.Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 30, 2025
Dec 30, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations)Nov 24, 2025
Nov 24, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 24, 2025
Nov 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2025
Oct 29, 2025Integrated Unaudited Financial Results And Limited Review Report For The Quarter And Half-Year Ended September 30 2025.Oct 28, 2025
Oct 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday October 28 2025Oct 28, 2025
Oct 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter Ended September 30 2025.Sep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 01, 2025
Aug 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2025
Jul 29, 2025Unaudited Financial Results For The Quarter Ended As On June 30 2025.Jul 29, 2025
Jul 29, 2025Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29 2025 Inter Alia For The Approval Of Unaudited Financial Statements For The Quarter Ending As On June 30 2025.Jul 29, 2025
Jul 29, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.05% | 0 | 0.00% | 0.00% | |
 HDFC Pharma And Healthcare Fund Direct-Growth | 0.10% | 0 | 0.00% | 0.10% | |
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 72.57
ATR(14)
Less Volatile 54.82
STOCH(9,6)
Neutral 76.47
STOCH RSI(14)
Oversold 5.98
MACD(12,26)
Bullish 4.05
ADX(14)
Very Strong Trend 55.69
UO(9)
Bearish 60.22
ROC(12)
Uptrend And Accelerating 17.40
WillR(14)
Neutral -24.57
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
